Pear Sports Partners with LIVMOR to Provide Remote Digital Fitness & Wellness Coaching for Veterans with Peripheral Artery Disease (PAD)
Pilot Study Will Assist Prescribing Physicians by Sending Personalized Exercise & Movement Instructions to PAD Patients to Improve Outcomes
NEWPORT BEACH, CA – October 28, 2019 - PEAR Sports, creators of the PEAR Health & Fitness Platform that delivers targeted smart coaching technology, today announced it has partnered with LIVMOR to develop digital fitness and wellness training programs that produce better outcomes and experiences for those suffering from Peripheral Artery Disease (PAD). LIVMOR, makers of the Halo+ Powered by Samsung medical-grade remote monitoring device, develops proprietary software solutions for wearable devices that continuously monitor the health and wellness of patients with chronic conditions. Together, LIVMOR and PEAR Sports will participate in a pilot study at the Dallas VA to serve Veterans with PAD.
“Fortunately, symptoms of PAD can be reduced and even eliminated with diet and exercise,” reports Ken Persen, Founder & CEO of LIVMOR. “This is the goal of the joint LIVMOR and PEAR Sports pilot study -- to interpret patient data, create personalized, actionable health coaching exercises, and send them directly to the Veterans to help reduce their symptoms and increase their overall quality of life. We are working together with the goal of delivering specific video and audio instructions directly to patients on their prescribed Halo+ tablet.” Ken added, “This is a great opportunity to use tele-health to extend the services provided to the Veteran population.”
The LIVMOR Coaching Platform Powered by Pear will be part of the prescriptive LIVMOR Halo+ program, currently in clinical trials, that provides an elegant turnkey solution for continuous remote monitoring of PAD patients. The LIVMOR solution uses the first prescription-only smartwatch for accurate remote monitoring of heart rate, heart rate variability and activity. This new digital coaching platform will deliver proactive wellness and exercise instructions targeted to improve patient results. The objectives of the pilot study, which is being performed in concert with the Dallas VA, are to monitor Veterans with PAD, and then provide custom and relevant fitness programs to reduce their symptoms and help them become healthier through proven exercise and wellness training.
“It is very rewarding to partner with a medical technology company like LIVMOR to provide digital wellness coaching solutions that will assist physicians and medical professionals in addressing chronic cardiovascular illness,” said Bob Allison, Founder of PEAR Sports. “We are particularly enthusiastic to work with LIVMOR to deliver engaging and effective exercise content to our Veteran population through the pilot study at the Dallas VA. We know the symptoms of cardiovascular disease can be alleviated with appropriate exercise and wellness programs, and we look forward to improving the wellness journey for Veterans suffering from PAD.”
PEAR Sports is perfecting the personalized delivery of digital health, wellness and fitness programs. Our platform and solutions deliver on-demand customized coaching that creates great experiences for customers and enterprises. For more information, visit www.pearsports.com.
About LIVMOR
LIVMOR develops proprietary algorithms and software solutions for wearable devices to provide continuous health and wellness monitoring for patients globally. For more information, visit www.livmor.com
Qunuba Sciences successfully earns a certificate for conformance with ISO 13485:2016 and the Medical Device Single Audit Program (MDSAP)
The company can now apply for Medical Device Licences on cannabis inhalational devices in rapidly growing medical cannabis markets, including Canada, Australia, New Zealand, Brazil, and the European Union.
TORONTO, Oct. 28, 2019 /CNW/ - Qunuba Sciences, a world leader in the development of cannabinoid delivery systems, is pleased to announce it has successfully earned a certificate for conformance with ISO 13485:2016 and the Medical Device Single Audit Program (MDSAP).
MDSAP is a rigorous audit process covering the requirements of ISO 13485:2016 as well as participating regulatory jurisdictions, including Australia (TGA), Brazil (ANVISA), Canada (Health Canada), Japan (MHLW), and the United States (FDA).
"This achievement is a key milestone for Qunuba Sciences as we approach marketing of the world's first medical-grade cannabinoid nebulization technology. Cannabis consumers in both the medical and wellness markets will have access to a safe alternative to burning or vaporizing cannabinoids without the unpredictable effect and slow-onset of edibles and oils," said Vijay Sappani, co-founder and director of Qunuba Sciences.
The emergence of Qunuba's technology directly addresses the need for trustworthy products in the inhalation of cannabis extracts. The precise-dosing device enables a more accessible intake experience due to the vaporless output of the underlying nebulization technology, meaning consumers can use the product in a wider range of settings than they are allowed with current vaping technology.
Qunuba Sciences' nebulization platform consists of a proprietary extraction and formulation method for producing aqueous cannabinoid solutions, coupled with an optimized handheld medical-grade inhalational device. Nebulization provides the same rapid onset of effect as smoking or vaping, but without requiring heating of the material and the resulting generation of toxic compounds. The proprietary aqueous cannabinoid solutions put safety first, using only inactive ingredients that are Generally Regarded as Safe (GRAS) and are also used in FDA-approved inhalational medicines.
Qunuba's multidisciplinary team of engineers and pharmacologists has successfully commercialized dozens of medical products approved by FDA, Health Canada, and other major regulators around the world. The team will continue to leverage this expertise to create innovative products that have a positive impact on for cannabis consumers.
About Qunuba Sciences
Qunuba Sciences, founded in 2018, is a privately owned Canadian company focused on the research, development, and commercialization of safe and effective cannabinoid technologies. For more information, please visit qunuba.com.
SOURCE Qunuba Sciences Inc.
Saudi Ministry of Health Raising Efforts on Tobacco Control
RIYADH, Saudi Arabia, Oct. 28, 2019 /PRNewswire/ -- As part of a move toward healthier citizens of the Kingdom and achieving the targets set in the Saudi Vision 2030, the Saudi Ministry of Health (MOH) under the leadership of HE the Minister Dr. Tawfig AlRabiah has successfully implemented several initiatives.
Saudi Arabia became one of the first countries to ratify World Health Organization (WHO) Framework Convention for Tobacco Control in 2005 and established the National Committee for Tobacco Control (NCTC). In 2017, the NCTC implemented the new 100% taxation on all tobacco products and enforced the no smoking law in public places including shopping malls, parks and workplaces. It has also banned tobacco advertisement and sponsorship and imposed Saudi regulations; restricting more than 60 types of imported products.
In 2018, the NCTC introduced an initiative in collaboration with the Interior Ministry focusing on prisons through raising awareness, treatment and facilitating smoke-free wings. It also collaborated with the Finance Ministry to raise the minimum price of tobacco products making it less accessible to the youngsters. Moreover, the Commerce Ministry has also established an electronic surveillance system that watches out for discount sales of tobacco products promotion in physical stores and in websites, penalizing violations.
Meanwhile, the MOH developed the Saudi clinical guidelines for tobacco cessation therapeutic program including the expansion of specialized clinics to 900 locations kingdomwide, ensuring easily accessible service and free medications to the needy. The MOH developed an electronic mobile application providing a wide variety of services to the public including awareness, prevention and treatment. The app also has a unique system for reporting violations of tobacco guidelines.
Collectively, these efforts resulted in a significant increase of clinic visits' rates by 213% and decreased imports of tobacco products by 54% in 2019. The percentage of individuals quitting smoking has reached 307%.
Furthermore, the NCTC collaborated with The University of Massachusetts in the field of research on tobacco. It also conducted the Global Adult Tobacco Survey in 12,800 households Kingdomwide in collaboration with WHO and the Center for Disease Control and Prevention CDC in Atlanta, which was used to collect national data on adult tobacco usage in KSA.
In close collaboration with WHO, Saudi Arabia became the first country in the Middle East applying plain packaging for tobacco products effective August 2019. Whereas the WHO has bestowed a global recognition award to Dr. Tawfig AlRabiah (Saudi Health Minister) for his efforts in combating tobacco addiction in May 2019 during the 72nd World Health Assembly.
"Saudi Arabia has an ambitious strategic tobacco control plan to reduce smoking rates from 12.7% to 5% by 2030, and we are aiming to implement tobacco control programs targeting school students soon," explains AlRabiah.
TORONTO, Oct. 25, 2019 /CNW/ - Moving adult smokers away from cigarettes to vaping products should be one of Ontario's public health goals. However, the recently announced ban on e-cigarette advertising at retail will limit adult smokers' ability to learn about alternative nicotine products.
"Adult consumers need to know the facts about vaping. With the news of vaping related illnesses, vapers don't know where to turn for accurate information. They need to know that vaping is less harmful than smoking. They need to know the science behind it. They need to know their options and how to use them. Imposing regulations that would further restrict communication about these products would only serve to keep smokers hooked on tobacco," said Helen Cran, a spokesperson for Rights4Vapers.com.
The data shows that adult smokers turn to vaping products to help them quit.
Right4Vapers.com surveyed 4,000 Canadian vapers. This survey is the largest consumer survey of vapers and their behaviour. The study found that 95 percent of respondents have used vapour products to quit smoking, and 98 percent of respondents smoke less because of vape use.
"We agree with responsible advertising. It shouldn't target minors or portray vaping as glamorous or safe. However, smokers need information on their products," said Ms. Cran.
Rights4Vapers.com is an organization of vaping advocates dedicated to the advancement of Canadian-based research on vaping. Dr. Chris Lalonde is an academic advisor.
[1] Tobacco Harm Reduction Approaches to Smoking, UK National Institute for Health and Care Excellence, public health guidance 45, July 2013
SOURCE Rights 4 Vapers
Ontario Medical Association Applauds Restrictions to Promotion of Vaping Products in Convenience Stores and Gas Stations
TORONTO, Oct. 25, 2019 /CNW/ - The Ontario Medical Association (OMA) strongly supports this move by the Ontario Government to address the issue of youth vaping by banning the promotion of vapour products in convenience stores and gas stations.
Our position is clear: vaping devices should not be used by non-smokers and especially not by young people.
The OMA wrote to Minister Elliott in September and recommended that the government:
Expand restrictions on the marketing and promotion of vaping products.
Expand restrictions of flavouring for vape juice, e-juice and e-liquid.
Develop awareness campaigns to educate the public, especially youth, about the harmful risks of vaping.
"On behalf of Ontario's doctors, I applaud today's announcement by Health Minister Christine Elliott that will restrict promotion of vaping products in convenience stores and gas stations," said Dr. Sohail Gandhi, President, OMA. "This is an important first step towards ensuring that these products are not marketed to youth. I also thank the Minister for inviting the OMA to participate in the Minister's roundtables to discuss this issue. We look forward to continuing to work with the government to protect youth from the dangers of vaping."
According to the most recent Canadian Tobacco, Alcohol and Drugs Survey, 23 per cent of students in Grades 7-12 have tried a vaping product, many of which contain nicotine.
There is a lack of awareness and understanding among youth about the addictive nature of nicotine and the potential negative health effects. There is evidence that youth who use vaping devices are more likely to smoke tobacco later in life.
The OMA has long advocated for robust smoking cessation programs. Vaping products have helped some people stop smoking, although the evidence on their effectiveness is inconclusive.
About the OMA
The Ontario Medical Association represents Ontario's 43,000 plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system.
SOURCE Ontario Medical Association
How to Handle Your Indoor Winter Workouts Without Going Stir Crazy
Winter. That magical time of year when even your best outdoor plans tend to get ruined. This includes your regularly planned workouts, leaving you with a difficult decision: do you take your workouts inside and risk going stir crazy, or do you chance a miserable workout outside? Fortunately, you don’t have to make this difficult decision. With a few small adjustments, you can make your indoor workouts enjoyable, allowing you to keep your body (and mind) fit all winter long.
Invite a Friend
All workouts are more enjoyable with a friend, but especially those workouts that find you stuck inside. With a workout partner, you’ll have someone to keep you accountable and motivated, help share the misery of being cooped up inside, and to enjoy good conversation with once the workout is done. What’s more, your friend can help suggest tips to help make your workout better, resulting in increased fitness for both of you.
Keep the Temperature Right
One of the most difficult parts of working out indoors is properly regulating your body temperature. Since it’s the winter, you’ll likely have the heat on in your home. However, once you get into the heart of your workout, you may quickly find that what’s comfortable when you’re resting is miserable when you’re exerting yourself. Therefore, you must be prepared to turn on your air conditioner, even when the temperature outside might dictate otherwise. Just be sure your system is in good working order by having a local professional, like Robison Air, give it a thorough inspection.
Plan an Escape
A great way to motivate yourself for indoor winter workouts is to reward yourself after your workouts more than you normally would. For example, you may not normally reward yourself with a bubble bath after a run outside. However, to push yourself during that indoor workout, you can set aside time afterward for a juicy reward that will keep your eyes on the goal. Whatever you do, though, it’s important to avoid too many food rewards, as that could reverse the progress you make during your workout.
Set the Mood
It’s difficult to exercise inside during the winter, especially when what you’d rather be doing is running on the beach of a secluded tropical island. If you have space, though, you can bring the island to you instead of having to bring yourself to an island. You can include tropical plants in your workout space and even find videos of various tropical locations to play during your workouts. While it won’t be a substitute for the feeling of the sand between your toes, it will help tide you over until you’re able to get outside again.Keep Moving Forward
Acorn Biolabs partners with Executive Health Centre to become first clinic in North America to offer non-invasive stem cell collection
TORONTO, Oct. 23, 2019 /CNW/ - Acorn Biolabs, a pioneer in non-invasive stem cell collection, today announced a strategic partnership with Toronto-based Executive Health Centre, a medical wellness centre and leader in precision and personalized medicine. Under the agreement, Executive Health Centre will become the first clinic in North America to offer its patients the ability to have their stem cells banked through a method that involves simply plucking a few hair follicles from a person's head.
Acorn's innovative method allows for full genome collection without the need for surgery or other painful and invasive procedures, making stem cell collection significantly more affordable and accessible for everyone.
"Our partnership with Acorn is tremendously exciting for the future of healthcare," says Dr. Elaine Chin, founder of Executive Health Centre. "Stem cells play a critical role in predictive analytics and will allow us to identify and prevent diseases before they happen, in addition to creating the possibility for an array of personalized regenerative treatments in the future."
Once stem cells are collected, Acorn uses a proprietary method of keeping cells viable during transport and storage, turning collected hair follicles into a highly valuable and accessible resource for regenerative medicine and genetics. Not only are these stem cells securely stored for future use, but the company's scientists can also extract critical genetic information that will unlock valuable data about a person's health that has never been available before. With this partnership, Executive Health Centre patients will also have access to Acorn's genetic age reports that provide insights into a person's aging process.
"Dr. Chin has been a trailblazer in using biometric and monitoring technology with her patients, and has established herself as an eminent thought leader in this space. For Acorn to combine our technology with her clinic's expertise is a major win not just for patients, but also for the broader industry as a whole," says Dr. Drew Taylor, co-founder and CEO of Acorn. "Both Executive Health Centre and Acorn strongly believe that our cells are the future of healthcare, and we're thrilled to be working together in making regenerative medicine accessible to more and more people."
Media Availability Time: 4:00 p.m. Location: Executive Health Centre, 4120 Yonge Street, Toronto, ON Dr. Drew Taylor and Dr. Elaine Chin are available for interviews.
About Acorn Biolabs, Inc. Founded in 2017 by Steven ten Holder, Patrick Pumputis and Dr. Drew Taylor and borne out of years of research, Acorn is a healthcare technology company. Based at Johnson & Johnson INNOVATION JLABS in Toronto, Acorn is focused on giving every human being the best chance to experience more healthy years with its easy, affordable and non-invasive live-cell collection, analysis and cryopreservation service. Acorn helps you live a longer, healthier tomorrow by freezing the clock on your cells today. Visit www.acorn.me.
About Executive Health Centre The Executive Health Centre is recognized for its visionary work in personalized, preventative healthcare. Dr. Elaine Chin, founder of the Executive Health Centre, established North America's first physician and naturopathic doctor-integrated health clinic in 1997 at the Mississauga Hospital (now Trillium Health Partners). Today, the combined expertise of this innovative model is unmatched in North America and provides its patients the best in seamless integrative medicine and rejuvenation therapies. Dr. Chin is also the author of "Lifelines – Unlocking the Secrets of Your Telomeres for a Longer, Healthier Life," on The Globe and Mail's Top 10 Bestseller List. Visit: www.executivehealthcentre.com.
SOURCE Acorn Biolabs
Walmart offering free health screenings at Wellness Day events
Walmart pharmacists on-hand to meet customers and offer services
MISSISSAUGA, ON, Oct. 23, 2019 /CNW/ - With 60 per cent of all households in Canada living within a 10-minute drive of a Walmart store, Walmart pharmacists can be one of the most accessible healthcare providers, offering expert advice and compassion on healthcare issues.
This coming Saturday, Canadians in communities across the country can meet one of the more than 1,150 licensed pharmacists, like Cecile San Jose (Brampton, Ontario) offering healthcare services at Walmart.
As part of the annual Wellness Day (October 26 from 10 a.m. to 2 p.m.), customers will receive complimentary healthcare services including, glucose checks, blood pressure checks, flu vaccinations, and consultations with their local pharmacist about any health concerns.
San Jose has been a pharmacist for nearly a decade and has spent more than half of her career at Walmart. She recognizes the important role that pharmacists play in helping Canadians make their health a priority and sees Walmart's Wellness Day as a valuable opportunity to promote good health.
"At Walmart, part of our mission is to help Canadians live better. As a pharmacist that means helping people live healthier lives," said San Jose. "Our free Wellness Day screenings can help Canadians discover underlying issues like high blood pressure and diabetes, which they can then manage. Not only do we want Canadians to live better, we want them to stay well."
Walmart Canada launched its first Wellness Day in last spring and provided more than 11,000 free health screenings.
One-stop health shop
Every year, hundreds of thousands of Canadians are supported by Walmart pharmacists. These important services are one part of Walmart's health and wellness offering, which also includes vision centres (in select stores), medical clinics (in select stores) and access to affordable products that support good health.
"Whether customers are embarking on a new path to wellness or continuing on their journey, Walmart's licensed pharmacists can help," said Shelly Kiroff, senior vice president, health and wellness at Walmart Canada. "At a time when new health trends are constantly emerging, our pharmacists can help Canadians understand what's best for them."
About Walmart Canada Walmart Canada operates a growing chain of more than 400 stores nationwide serving more than 1.2 million customers each day. Walmart Canada's flagship online store, Walmart.ca is visited by more than 750,000 customers daily. With more than 85,000 associates, Walmart Canada is one of Canada's largest employers and is ranked one of the country's top 10 most influential brands. Walmart Canada's extensive philanthropy program is focused on supporting Canadian families in need, and since 1994 Walmart Canada has raised and donated more than $400 million to Canadian charities. Additional information can be found at walmartcanada.ca, facebook.com/walmartcanada and at twitter.com/walmartcanada.
Women living with metastatic breast cancer in British Columbia now have public access to KISQALI®
DORVAL, QC, Oct. 23, 2019 /CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that British Columbia will now reimburse KISQALI® (ribociclib) for eligible patients in combination with an aromatase inhibitor (letrozole) under its provincial public drug program (complete British Columbia reimbursement criteria can be accessed here).1
For women living with metastatic breast cancer, also known as Stage IV breast cancer, the cancer has spread beyond the breast to other areas of the body, such as the lungs, liver, bones or brain.2 It may happen before or after treatment, or it may develop from reoccurring breast cancer.3 Although there have been advancements in early detection and treatment, there is still no cure for metastatic breast cancer.4 While overall 5-year survival rates for female breast cancer are relatively high, at 87%, women with advanced breast cancer face a 22% survival rate over 5 years.5
"The reimbursement of ribociclib (KISQALI®) in British Columbia and certain other parts of Canada provides women living with advanced breast cancer with more treatment options that may potentially delay the progression of breast cancer and improve the duration and quality of their survival," said Dr. Karen Gelmon, Professor of Medicine, UBC and Medical Oncologist, BC Cancer.
"We are pleased that British Columbia has joined certain other Canadian provinces in providing women living with metastatic breast cancer with much needed treatment options that can help improve their quality of life," said Cathy Ammendolea, Chair of the Board of Directors, Canadian Breast Cancer Network.
KISQALI® belongs to a family of medications called protein kinase inhibitors. These medications work by stopping cancer cells from dividing and growing.KISQALI® received Health Canada approval for use with letrozole on March 2, 2018, for the treatment of postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer as first-line endocrine-based therapy based on findings from the pivotal MONALEESA-2 trial. When given together with letrozole, KISQALI® may help slow down the growth and spread of breast cancer cells.6
"Our work in this therapeutic area has helped to improve the well-being of Canadians living with breast cancer," said Daniel Hébert, Country Medical Head Oncology, Novartis Pharmaceuticals Canada Inc. "The addition of KISQALI® to the public drug plan in British Columbia is a promising milestone for women living with metastatic breast cancer and the entire breast cancer community in Canada. As a leader in the healthcare field, we will continue to work with the remaining provinces and territories to ensure all Canadians living with metastatic breast cancer and their healthcare providers have public access to KISQALI®."
About KISQALI®(ribociclib) KISQALI® is a selective cyclin-dependent kinase inhibitor, a class of drugs that help slow the progression of cancer by inhibiting two proteins called cyclin-dependent kinase 4 and 6 (CDK4/6). These proteins, when over-activated, can enable cancer cells to grow and divide too quickly. Targeting CDK4/6 may play a role in ensuring that cancer cells do not continue to replicate uncontrollably. KISQALI® was developed by the Novartis Institutes for BioMedical Research (NIBR) under a research collaboration with Astex Pharmaceuticals.
About Novartis in Advanced Breast Cancer Novartis tackles breast cancer with advanced science, collaboration and a passion for transforming patient care. We've taken a bold approach to our research by including patient populations often neglected in clinical trials, identifying new pathways or mutations that may play a role in disease progression and developing therapies that not only maintain, but also improve, quality of life for patients. Our priority over the past 30 years and today is to deliver treatments proven to improve and extend lives for those diagnosed with advanced breast cancer.
About Novartis Pharmaceuticals Canada Inc. Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2018, the company invested $52 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 1,000 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.
5 Canadian Cancer Society. Canadian Cancer Statistics, a 2018 special report on cancer incidence by stage. Available at: www.cancer.ca/Canadian-Cancer-Statistics-2018-EN. Accessed on October 2, 2019.
ChristianaCare Vaccinates 8,035 Employees in 4 States in 100 Locations from the Flu through #HitMeWithYourFluShot
Nearly Two-Thirds of Workforce Vaccinated during Single-Day Event (WILMINGTON, Del. – Oct. 23, 2019) Downloadable:PHOTOSVIDEO For the second year in a row, ChristianaCare vaccinated the majority of its 12,000 caregivers from the flu in a single day in a fun-filled event called #HitMeWithYourFluShot. The event is designed to support ChristianaCare’s voluntary employee vaccination campaign that annually tops 90% of all employees vaccinated. The single-day event also doubles as an emergency preparedness drill, simulating the logistical challenges that would need to be managed if the health system ever needed to rapidly mobilize to vaccinate all of its employees in an emergency.In a one-day blitz that spanned 100 locations in four states, from 3 a.m. to 9 p.m., ChristianaCare vaccinated 8,035 caregivers, beating its target and eclipsing last year’s record of 7,868.“Our #HitMeWithYourFluShot campaign is a shining example of how we serve together, guided by our values of Love and Excellence,” said Marci Drees, M.D., MS, FACP, DTMH, FSHEA, chief infection prevention officer and hospital epidemiologist. “By vaccinating so many of our caregivers in a single day, we protect our employees, our patients and our community from influenza. We also lead by example, demonstrating the importance that everyone get an annual flu vaccination.”During the event, flu vaccination stations operated for 18 consecutive hours at ChristianaCare’s two hospital campuses—Newark and Wilmington. At ChristanaCare’s satellite sites in Delaware, Pennsylvania, Maryland and New Jersey—nearly 100 locations — roving teams dropped off vaccination kits or administered vaccines so caregivers could quickly and easily get vaccinated. Those sites include primary care, specialty care, medical aid units, imaging, laboratory, rehabilitation services and non-clinical sites.Enhancing the drill this year was the option of a drive-through vaccination station at ChristianaCare’s Newark campus. Employees who were not working that day could get vaccinated against the flu without ever departing their car. Many employees who used the drive-through location were able to cruise through while running their errands for the day, sometimes with the kids or family dog in the car.Employees were encouraged to pre-register for their flu shot using paperless forms in the weeks leading up to the drill, which improved the efficiency of the actual event.Between 36,400 and 61,200 Americans died from the flu last year, according to the U.S. Centers for Disease Control and Prevention. In addition, the flu hospitalized more than 500,000 people and sickened 40 million Americans.Employees who were not vaccinated during the event will have other opportunities to get vaccinated this year.About ChristianaCare Headquartered in Wilmington, Delaware, ChristianaCare is one of the country’s most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. ChristianaCare includes an extensive network of outpatient services, home health care, medical aid units, two hospitals (1,227 beds), a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. It also includes the pioneering Gene Editing Institute and was rated by IDG Computerworld as one of the nation’s Best Places to Work in IT. ChristianaCare is a not-for-profit teaching health system with more than 260 residents and fellows. We are continually ranked by US News & World Report as a Best Hospital. With our unique, data-powered care coordination service and a focus on population health and value-based care, ChristianaCare is shaping the future of health care. Learn how we deliver greater quality and value at https://christianacare.org.####
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
